Skip to main content
. Author manuscript; available in PMC: 2019 Aug 6.
Published in final edited form as: Eur Urol. 2017 Sep 28;73(1):62–68. doi: 10.1016/j.eururo.2017.09.008

Fig. 3 –

Fig. 3 –

Kaplan-Meier estimates of overall survival (OS) in the intent-to-treat population. * Two-sided p value from log-rank test stratified by University of California, Los Angeles integrated staging system high-risk group: T3 or T4, no or undetermined nodal involvement, no metastasis, or any T stage with local nodal involvement, and for all patients, any Fuhrman grade and any Eastern Cooperative Oncology Group performance status. CI = confidence interval; ECOG PS =; HR = hazard ratio; NR = not reached.